Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Reiterates Overweight on Zoetis, Lowers Price Target to $195

Author: Benzinga Newsdesk | April 16, 2024 10:24am
Piper Sandler analyst David Westenberg reiterates Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $220 to $195.

Posted In: ZTS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist